JP2011504099A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504099A5
JP2011504099A5 JP2010532633A JP2010532633A JP2011504099A5 JP 2011504099 A5 JP2011504099 A5 JP 2011504099A5 JP 2010532633 A JP2010532633 A JP 2010532633A JP 2010532633 A JP2010532633 A JP 2010532633A JP 2011504099 A5 JP2011504099 A5 JP 2011504099A5
Authority
JP
Japan
Prior art keywords
antibody
sequence
monoclonal antibody
sialylated
neu5gc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010532633A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011504099A (ja
Filing date
Publication date
Priority claimed from FI20070853A external-priority patent/FI20070853A0/fi
Application filed filed Critical
Publication of JP2011504099A publication Critical patent/JP2011504099A/ja
Publication of JP2011504099A5 publication Critical patent/JP2011504099A5/ja
Pending legal-status Critical Current

Links

JP2010532633A 2007-11-09 2008-11-10 シアリルルイスc、シアリルTn、及びN−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法 Pending JP2011504099A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20070853A FI20070853A0 (fi) 2007-11-09 2007-11-09 Glykaania sitovat monoklonaaliset vasta-aineet
PCT/FI2008/050643 WO2009060129A1 (en) 2007-11-09 2008-11-10 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes

Publications (2)

Publication Number Publication Date
JP2011504099A JP2011504099A (ja) 2011-02-03
JP2011504099A5 true JP2011504099A5 (enExample) 2011-12-22

Family

ID=38786638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532633A Pending JP2011504099A (ja) 2007-11-09 2008-11-10 シアリルルイスc、シアリルTn、及びN−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法

Country Status (7)

Country Link
US (1) US20100292095A1 (enExample)
EP (1) EP2209809A4 (enExample)
JP (1) JP2011504099A (enExample)
AU (1) AU2008324073A1 (enExample)
CA (1) CA2743032A1 (enExample)
FI (1) FI20070853A0 (enExample)
WO (1) WO2009060129A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095418A0 (fi) * 2009-04-16 2009-04-16 Suomen Punainen Risti Veripalv Kryptinen subpopulaatio
US8452875B2 (en) * 2008-10-13 2013-05-28 Mitsubishi Electric Corporation Resource allocation apparatus, resource allocation program and recording media, and resource allocation method
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
HUE038423T2 (hu) 2012-12-07 2018-10-29 Glycomimetics Inc E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
MX2017006167A (es) 2014-11-12 2018-03-23 Siamab Therapeutics Inc Compuestos que interactúan con glicanos y métodos de uso.
CN107108679B (zh) 2014-12-03 2020-10-23 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
US20180320136A1 (en) * 2015-11-03 2018-11-08 GlycoMimitics, Inc. Methods and compositions for the production of monoclonal antibodies, hematopoietic stem cells, and methods of using the same
CA3002097A1 (en) 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
BR112019006642A2 (pt) 2016-10-07 2019-07-02 Glycomimetics Inc antagonistas multiméricos de e-selectina altamente potentes
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
GB201703212D0 (en) * 2017-02-28 2017-04-12 Nat Univ Ireland Galway The detectionm quantification and discrimination of the sialic acid N-glycolylneuraminic (Neu5Gc) acid and N-acetylneuraminic acid (Neu5gc)
KR20240044544A (ko) 2017-03-03 2024-04-04 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (en) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
PT110526B (pt) 2018-01-26 2021-02-04 Univ Nova De Lisboa Anticorpo, fragmento funcional ou sonda do mesmo contra antigénios tumorais
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
WO2020055768A1 (en) * 2018-09-10 2020-03-19 Cold Spring Harbor Laboratory Methods for treating pancreatitis
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4965198A (en) * 1985-12-24 1990-10-23 Konica Corporation Monoclonal antibody and method of manufacturing hybridoma producing the same
US4949778A (en) * 1987-12-16 1990-08-21 Kawasaki Steel Corporation Immersion nozzle for continuous casting
DE4208795A1 (de) * 1992-03-19 1993-09-23 Behringwerke Ag Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum
US7682794B2 (en) * 2003-07-15 2010-03-23 The Regents Of The University Of California Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
FI20055398A0 (fi) * 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
WO2007054622A1 (en) * 2005-11-08 2007-05-18 Suomen Punainen Risti, Veripalvelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
WO2008000918A1 (en) * 2006-06-29 2008-01-03 Suomen Punainen Risti, Veripalvelu Novel cellular glycan compositions
US20100145032A1 (en) * 2007-01-18 2010-06-10 Suomen Punainen Risti, Veripalelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
CA2712562A1 (en) * 2007-01-18 2008-07-24 Glykos Finland Ltd Novel specific cell binders
CA2712556A1 (en) * 2007-01-18 2008-07-24 Glykos Finland Ltd Novel carbohydrate from human cells and methods for analysis and modification thereof

Similar Documents

Publication Publication Date Title
Saeed et al. Antibody engineering for pursuing a healthier future
JP2011504099A (ja) シアリルルイスc、シアリルTn、及びN−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法
Linman et al. Surface plasmon resonance study of protein-carbohydrate interactions using biotinylated sialosides
HRP20250850T1 (hr) Antitijela protiv claudina 18.2 korisna u dijagnozi raka
JP2009533021A5 (enExample)
WO2013054331A8 (en) Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
NZ717429A (en) Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102703453A (zh) 特异性识别链霉素的dna适配体及其应用
RU2013142334A (ru) КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ ДЛЯ ОПРЕДЕЛЕНИЯ НЕ4а
MX2025004565A (es) Anticuerpos anti-cd3 dependientes de ph y metodos relacionados con estos
WO2005010485A3 (en) Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
US20210017564A1 (en) Antigen treatment method
EP3273241B1 (en) Method and kit for detecting stem cell
RU2009124225A (ru) Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis
CA3115887A1 (en) Antibodies specific for glycosylated apoj and uses thereof
US20110045497A1 (en) Novel acidic glycan markers of human cells
US8043852B2 (en) Monoclonal antibody specific to dentin-derived heparan sulfate
JP2024513880A (ja) 免疫組織化学法およびkir3dl2特異的薬剤
JP5711877B2 (ja) 癌の悪性度の検知方法及び癌の悪性度の診断剤
ATE476449T1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
EA201490286A1 (ru) Моноклональные антитела, специфичные в отношении x-37 бета-амилоида, и пути их применения
JP2020162572A (ja) 抗原の処理方法。
WO2024015522A1 (en) Methods for analyzing extracellular vesicles and microbes
Miyamoto et al. Inhibition of Prion Propagation in Scrapie-infected Cell Lines using Mouse Monoclonal Antibodies against Prion Protein